{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T21:01:44Z","timestamp":1779397304903,"version":"3.53.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministry of Education, Science, and Technological Development of the Republic of Serbia","doi-asserted-by":"publisher","award":["175090"],"award-info":[{"award-number":["175090"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007802","name":"Italian Ministry of Health, AriSLA (Fondazione Italiana di Ricerca per la SLA)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007802","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Education and Science, Republic of Serbia"},{"name":"Serbian Academy of Science and Arts"},{"DOI":"10.13039\/100006314","name":"Biogen Idec","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006314","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Merck Serono"},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla"},{"name":"Cure PSP"},{"name":"Alzheimer's and Drug Discovery Foundation"},{"name":"Jacques and Gloria Gossweiler Foundation (Switzerland)"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.parkreldis.2018.01.001","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T03:10:30Z","timestamp":1515035430000},"page":"95-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Progression of white matter damage in progressive supranuclear palsy with predominant parkinsonism"],"prefix":"10.1016","volume":"49","author":[{"given":"Francesca","family":"Caso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Agosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Je\u010dmenica-Luki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Petrovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Meani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir S.","family":"Kostic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5485-0479","authenticated-orcid":false,"given":"Massimo","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2018.01.001_bib1","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awh488","article-title":"Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism","volume":"128","author":"Williams","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2018.01.001_bib2","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/mds.26054","article-title":"The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases","volume":"29","author":"Respondek","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2018.01.001_bib3","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/mds.27038","article-title":"Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be?","volume":"32","author":"Whitwell","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2018.01.001_bib4","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.neurobiolaging.2012.02.002","article-title":"Diffusion tensor MRI contributes to differentiate Richardson's syndrome from PSP-parkinsonism","volume":"33","author":"Agosta","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.parkreldis.2018.01.001_bib5","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00234-011-0983-7","article-title":"In\u00a0vivo evaluation of white matter pathology in patients of progressive supranuclear palsy using TBSS","volume":"54","author":"Saini","year":"2012","journal-title":"Neuroradiology"},{"key":"10.1016\/j.parkreldis.2018.01.001_bib6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","author":"Hoglinger","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2018.01.001_bib7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.parkreldis.2011.05.013","article-title":"Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study","volume":"17","author":"Whitwell","year":"2011","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2018.01.001_bib8","article-title":"Diffusion tensor imaging of Parkinson's disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics study","volume":"9","author":"Worker","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2018.01.001_bib9","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.neurobiolaging.2014.03.028","article-title":"Clinical correlations of microstructural changes in progressive supranuclear palsy","volume":"35","author":"Tessitore","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.parkreldis.2018.01.001_bib10","first-page":"913","article-title":"Clinical, cognitive, and behavioural correlates of white matter damage in progressive supranuclear palsy","volume":"261","author":"Agosta","year":"2014","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.parkreldis.2018.01.001_bib11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneurol.2011.107","article-title":"Clinical correlates of white matter tract degeneration in progressive supranuclear palsy","volume":"68","author":"Whitwell","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2018.01.001_bib12","article-title":"Progression of microstructural degeneration in progressive supranuclear palsy and corticobasal syndrome: a longitudinal diffusion tensor imaging study","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2018.01.001_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049072","article-title":"Diffusion tensor metrics as biomarkers in Alzheimer's disease","volume":"7","author":"Acosta-Cabronero","year":"2012","journal-title":"PLoS One"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802018300014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802018300014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T14:46:50Z","timestamp":1657464410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802018300014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":13,"alternative-id":["S1353802018300014"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.01.001","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progression of white matter damage in progressive supranuclear palsy with predominant parkinsonism","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}